Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.
Cultural influencers take off their blindfolds to destigmatize HIV prevention in ViiV’s “Me in You, You in Me” campaign. [VIDEOS]
ViiV Healthcare’s Risk to Reasons initiative offers stigma-free language for discussing HIV and Black women. Apply now for grants.
The Women as the Face of AIDS Summit, organized by Iris House, also honored three trailblazing women working to end the HIV epidemic.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
Using the new dosing schedule, injectable cabotegravir and rilpivirine can be administered just six times a year.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
After years of taking daily oral cabotegravir and Edurant, people with suppressed HIV switched to long-acting injectable Cabenuva.
Nine key insights from over 760 interviews for ViiV Healthcare’s “Here as I Am” report.
A global study examined how outcomes improve when physicians engage their HIV-positive patients in joint decision-making.
A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.
Bonus: Your donations to the Broadway Cares effort Emergency Grants for Pandemic Relief will be matched by Gilead Sciences.
Who got what and why? NMAC’s Paul Kawata addresses criticism and breaks down the data.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
ViiV Healthcare has given
about $6 million to 99 projects in 26 countries to improve the health of women,
children and families affected by...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.